The American Society of Clinical Oncology (ASCO) will join the President’s Cancer Panel on Sept. 7 to highlight the numerous ways ASCO is working to advance the National Cancer Plan and achieve the president’s Cancer Moonshot goal of “ending cancer as we know it.”
ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.
To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.
September 5, 2023
August 1, 2023
Prior to leaving Washington, D.C., to spend the August recess in their states and districts, members of Congress engaged in a flurry of July activity on issues the Association for Clinical Oncology (ASCO) is tracking closely.
July 13, 2023
On July 13, 2023, the Centers for Medicare & Medicaid Services (CMS) released its proposed rule for the 2024 Medicare Physician Fee Schedule (PFS) and updates to the Quality Payment Program (QPP). The agency also released the 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System proposed rule.
July 7, 2023
On July 7, 2023, the Centers for Medicare & Medicaid Services (CMS) released its proposed rule to reimburse hospitals that were underpaid under the 340B drug pricing program since 2018.
June 29, 2023
The American Society of Clinical Oncology (ASCO) has issued a statement regarding the U.S. Supreme Court decision on affirmative action.
March 21, 2023
The Association for Clinical Oncology (ASCO) recently submitted a response to an RFI from the Senate HELP Committee, focusing on current oncology workforce demographics, drivers of oncology shortages across the care team, lack of workforce diversity, and the distribution of oncology professionals across rural America.
February 2, 2023
Dedicated to making a world of difference in cancer care, the American Society of Clinical Oncology and its affiliated organization, the American Association of Clinical Oncology (ASCO), laud the goals, progress, and continued potential of the Cancer Moonshot initiative. Having the full support of the President and the resources of the federal government is essential to our shared goal of accelerating the pace of progress against a disease that will be diagnosed in more than 1.9 million people in the U.S. this year.